The company did receive interim authorization in Canada in August, but the FDA took until November to recommend Lucira re-submit for a point-of-care approval. That would allow the test to be used ...

Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision.

The Navy granted CSRA an interim authorization to conduct a field test of the commercial off-the-shelf human resource management system in support of the service branch’s manpower, personnel ...

SANTA BARBARA, Calif. - The community can now test for COVID-19 and the flu at the same time from their home. The Food and Drug Administration (FDA) just granted the authorization of a COVID-19 ...

Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision.

GenMark’s test was developed for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples for patients suspected of COVID-19 by their health care provider. Rapid and easy ...

Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the ...

The Food and Drug Administration issued an emergency authorization for the first over-the-counter, at-home combination flu and Covid test on Friday, just two days after the company that makes the ...